Sukeshi Patel Arora
Mays Cancer Center · Cancer Therapy & Research Center University of Texas Health Science Center San Antonio · Cancer Therapy & Research Center at UTHSCSA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sukeshi Patel Arora as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:58 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03894917 · Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular CarcinomaThe University of Texas Health Science Center at San Antonio · recruiting · Carcinoma, Hepatocellular · principal investigator
- Ph2NCT03037437 · Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular CancerThe University of Texas Health Science Center at San Antonio · completed · Hepatocellular Cancer · principal investigator
- Ph1NCT02620423 · Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic AdenocarcinomaOncolytics Biotech · completed · Pancreatic Adenocarcinoma · principal investigator
- Ph2NCT02316340 · Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal CancerThe University of Texas Health Science Center at San Antonio · completed · Colorectal Cancer · principal investigator
- Ph1NCT01023737 · Hydroxychloroquine + Vorinostat in Advanced Solid TumorsThe University of Texas Health Science Center at San Antonio · completed · Malignant Solid Tumour · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:58 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study.Clin Cancer Res · 2020160 citationsRCR 6.2
- Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.Clin Cancer Res · 202558 citationsRCR 14.0
- Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.Cell Rep Med · 202343 citationsRCR 3.0
- Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).Br J Cancer · 202239 citationsRCR 2.8
- Left Versus Right: Does Location Matter for Refractory Metastatic Colorectal Cancer Patients in Phase 1 Clinical Trials?J Gastrointest Cancer · 20182 citationsRCR 0.1